TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06451757: KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Sponsor: Khondrion BV · Phase: PHASE3 · Area: CNS_NEUROLOGY · Target Enrollment: 220 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$7,437,960

Rescue Site Savings

+$4,903,544

Unlock Full NCT06451757 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06451757 Rescue Dossier →